Found 6 matching trials
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
PHASE2This study compares the safety and effectiveness of giving rivogenlecleucel...
Location
TriStar Bone Marrow Transplant, LLC
Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT
PHASE1This is a Phase I, multicenter, open-label, non-randomized study of matched...
Location
Multiple Locations
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
PHASE1This study will evaluate patients with blood cell cancers who are going to ...
Status
Active Not Recruiting
Location
Emory University Winship Cancer Institute
Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies
PHASE1This is an open-label, non-randomized study to evaluate the safety of two p...
Location
MD Anderson Cancer Center
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
PHASE1A Phase I study of BPX-501 T cell infusion in adults with recurrent or mini...
Status
Active Not Recruiting
Location
BMT Program at Northside Hospital
Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant
PHASE1Phase I, open-label, non-randomized study of safety, pharmacokinetics and e...
Status
Active Not Recruiting
Location
San Matteo Hospital